New UCSF-based center will
A new federally funded Center, based at UCSF, will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of disease in the Bay Area.
University of California San Francisco
Give to UCSF
Displaying 15901 - 15930 of 16406
-
-
HIV's assault on immune system
A UCSF-Gladstone Institute of Virology and Immunology (GIVI) Center for AIDS Research (CFAR) symposium titled, Immunology of HIV Infection will take place October 22 and 23, 2003.
-
Progress reported on diabetes, aging and childhood disease research
Top California scientists will report progress this week on studies of Alzheimer's Disease and other diseases of aging, as well as efforts to extend lifespan, develop cures for diabetes and improve diagnosis and treatment of childhood neurological disorders.
-
UCSF arthritis and joint replacement center will deliver comprehensive care
UCSF has opened a new Arthritis and Joint Replacement Center -- a joint effort between the departments of rheumatology and orthopedic surgery.
-
Scientists switch components in cell circuits: possible new technology, therapy
By tinkering with a few of the parts in a vital signaling circuit found in human cells, UCSF scientists have demonstrated the possibility of an entirely new technology: developing new devices or therapies by mixing and matching sub-cellular signaling components.
-
Combining osteoporosis drugs produces no added benefit
Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.
-
Researchers now on road to isolating skin stem cells
Researchers at the San Francisco VA Medical Center (SFVAMC) have taken the first major step toward isolating adult stem cells from mouse skin, having developed a test that confirms the presence and number of stem cells in a given amount of tissue.
-
UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
UCSF researchers have been funded by the National Institutes of Health to study the antiretroviral drug tenofovir as a potential pre-exposure prophylaxis in Cambodia among high-risk, HIV-uninfected women.
-
Pancreatic cancer linked to developmental cell signaling pathway
Scientists at UCSF and Massachusetts General Hospital (MGH) have found strong evidence that a cell signaling pathway active in embryonic development plays a crucial role in pancreatic cancer.
-
Comfort-food cravings may be body's attempt to put brake on chronic stress
UCSF researchers have identified a biochemical feedback system in rats that could explain why some people crave comfort foods - such as chocolate chip cookies and greasy cheeseburgers - when they are chronically stressed, and why such people are apt to gain weight in the abdomen.
-
Workplace exposure a significant cause of severe respiratory disease
Workplace exposure to dust or fumes may account for as many as five million cases of emphysema, chronic bronchitis and related diseases in the U.S. - diseases that have been mainly attributed to smoking, a new University of California, San Francisco survey shows.
-
Black women receive inadequate cardiac care compared to whites despite greater risk, study finds
Researchers have had few clues as to why Black women are more likely to die from heart attacks or strokes than white women.
-
Most resistance to anti-hiv drugs created by good pill-taking patients -- not by poor pill-takers
Resistance mutations to anti-HIV medications are more likely to occur in patients who take most of their medications rather than in those who don't, according to AIDS specialists at the University of California, San Francisco.
-
Scientists map signaling molecule crucial to survival, disease
A chemical sleight of hand by UCSF scientists has pinpointed for the first time where small molecules called phosphates bind to proteins in cells, allowing them to send signals and giving organisms a way to adapt to rapidly changing conditions.
-
California HMOs treat heart attack patients as well as traditional medical plans
HMO-enrolled Medicare patients who suffered a heart attack in California fared no worse -- perhaps even a little better -- than those who were covered by fee-for-service, according to a new UCSF study.
-
Short-Term Medical Cannabis Doesn't Harm HIV+ Patients
UCSF researchers found no harmful changes in HIV virus levels in patients on combination antiretroviral therapy in a safety study looking at both smoked marijuana and dronabinol, an oral medical cannabinoid.
-
UCSF Study Finds No Harm to HIV+ Patients with Short-Term Medical Cannabis
UCSF researchers found no harmful changes in HIV virus levels in patients on combination antretroiviral therapy in a safety study looking at both smoked marijuana and dronabinol, an oral medical cannabinoid.
-
Exercise your mind at the new UCSF Osher Lifelong Learning Institute
The UCSF Osher Lifelong Learning Institute (OLLI) starts in October with a series of classes aimed at adults over the age of 50 who remain curious, thoughtful, and in search of new ideas.
-
Most resistance to anti-hiv drugs created by good pill-taking patients -- not by poor pill-takers
Resistance mutations to anti-HIV medications are more likely to occur in patients who take most of their medications rather than in those who don't, according to AIDS specialists at the University of California, San Francisco.
-
Free counseling for seniors available as part of depression study
UCSF is offering 12 weeks of free individual counseling as part of a study on depression to adults 60 years and older who are feeling down, depressed, stressed, or who want help coping with medical, physical, or family problems.
-
Researchers Distinguish Between Kinds of Dementia Using Brain Imaging
Until now, scientists have been unable to distinguish between dementia caused by Alzheimer's disease and that caused by poor blood flow to the brain.
-
Pancreatic cancer linked to key step in malaria parasite's cycle, laying foundation for future drug
In a finding that could significantly enhance scientists' ability to develop and test drugs and vaccines to treat the most common and lethal form of malaria, a UCSF team has identified the full breadth of genetic activity at a key stage of development in the parasite Plasmodium falciparum.
-
Vitamins C and E improve cardiovascular health in children with high cholesterol, study says
An estimated 50 million children have high levels of the "bad" cholesterol--known as LDL--that puts them at high risk for suffering heart attacks as adults.
-
Vitamin C may protect against ulcer-causing bacteria, study finds
A study led by researchers at the San Francisco VA Medical Center (SFVAMC) has found that the lower the level of vitamin C in the blood the more likely a person will become infected by Helicobacter pylori, the bacteria that can cause peptic ulcers and stomach cancer.
-
UCSF Women's Health Conference on March 22 offers information for women of all ages
-
UCSF study finds no cases of HIV transmission from receptive oral sex
-
Physician assistants, nurses and family physicians more likely to care for underserved, study says
A first-time look at who is providing health care to the neediest populations in California and Washington states reveals that physician assistants, nurses and family physicians are more likely than others in primary care to serve the underserved.
-
Computer tool improves HIV risk behavior self-reporting in Africa
A computer and headphone self-interviewing system yielded higher self-reports of several key HIV risks behaviors and was the preferred interview method by Zimbabwean women in Africa, according to a study by UCSF researchers.
-
Zimbabwean women value diaphragm as clandestine method to possibly prevent HIV
Almost half of Zimbabwean women in a UCSF study say that the ability to use a diaphragm clandestinely was very or extremely important--a number that rises to 80 percent if their partners have other sexual partners or if getting their partners to use condoms is difficult.
-
UCSF-led team discovers possible cancer 'susceptibility' gene
A UCSF-led team has identified a common variant of a gene known as Aurora2 that may increase susceptibility to cancer development. The finding provides one of the first examples of an elusive type of "low penetrance" tumor susceptibility gene in humans.